‘Molecular Glue’ Activates Immune System to Combat Neuroblastoma
In a groundbreaking advance that heralds a new era in pediatric oncology, researchers at St. Jude Children’s Research Hospital have unveiled a promising therapeutic strategy to combat neuroblastoma, a devastating childhood cancer notorious for its complexity and resistance to treatment.